#lung cancer

With the HIV population aging, it is increasingly at risk of such age-related cancers.

As the lung cancer community and the lung cancer movement grew, the awareness activities increased and grew into Lung Cancer Awareness Month.

Cancer Health Basics offer need-to-know health facts on a variety of cancer topics from A-Z.

Imfinzi tripled progression-free survival in previously treated patients with inoperable lung cancer.

Canakinumab was associated with lower lung cancer risk in a large cardiovascular study.

Researchers urge against overreliance on nontraditional treatments.

New report shows that people in rural areas of the United States are less likely to develop cancer but more likely to die of it.

A recent study found that from 1995 to 2009, 10 percent of all deaths among a large cohort of people on HIV treatment were cancer-related.

Two targeted therapies, Tafinlar and Mekinist, for non-small-cell lung cancer with a specific BRAF mutation have been approved.

Two types of treatment targeting different genetic mutations show promising results in clinical studies.

Findings from three clinical trials of larotrectinib were presented at this year’s American Society of Clinical Oncology in Chicago.

Results from an animal study found common table sugar may increase the risk of both breast and lung cancer later in life.

Study shows racial disparities in the treatment of non-small cell lung cancer in the United States.